MarketCap
Facebook
X
Telegram
AlloVir EV - Enterprise Value | ALVR
Annual EV - Enterprise Value AlloVir
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -55.1 M | 68.2 M | -41.6 M | 422 M | 672 M | 1.25 B | 191 M | 55.9 M | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.25 B | -55.1 M | 321 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cytokinetics, Incorporated
CYTK
|
1.97 B | $ 60.7 | -0.87 % | $ 7.29 M |  USA |
 |
Daré Bioscience
DARE
|
21.8 M | $ 0.64 | -0.33 % | $ 7.15 M | USA |
 |
DBV Technologies S.A.
DBVT
|
2.69 B | $ 9.97 | 2.21 % | $ 1.39 B |  France |
 |
Denali Therapeutics
DNLI
|
2.34 B | $ 18.66 | 1.35 % | $ 3.22 B | USA |
 |
Precision BioSciences
DTIL
|
16 M | $ 6.4 | -3.61 % | $ 82.1 M | USA |
 |
Dyadic International
DYAI
|
35.6 M | $ 0.43 | 7.72 % | $ 15.6 M | USA |
 |
Enlivex Therapeutics Ltd.
ENLV
|
434 M | $ 0.16 | -7.21 % | $ 7.31 M |  Israel |
 |
Enanta Pharmaceuticals
ENTA
|
184 M | $ 12.0 | 3.09 % | $ 256 K | USA |
 |
Entera Bio Ltd.
ENTX
|
85.4 M | $ 2.83 | -3.25 % | $ 131 M | Israel |
 |
Passage Bio
PASG
|
10.1 M | $ 3.36 | -0.33 % | $ 10.8 M | USA |
|
Forte Biosciences
FBRX
|
280 M | $ 76.99 | 0.03 % | $ 997 M | USA |
 |
Exelixis
EXEL
|
11.9 B | $ 65.14 | 0.95 % | $ 17.7 B | USA |
|
Immatics N.V.
IMTX
|
389 M | $ 7.16 | -2.12 % | $ 876 M |  Germany |
 |
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M |  Canada |
 |
Gilead Sciences
GILD
|
176 B | $ 158.71 | 1.71 % | $ 197 B | USA |
 |
Grifols, S.A.
GRFS
|
16.3 B | $ 7.91 | 4.56 % | $ 5.38 B |  Spain |
 |
GlaxoSmithKline plc
GSK
|
258 B | $ 51.12 | 0.73 % | $ 207 B |  Britain |
 |
Halozyme Therapeutics
HALO
|
12 B | $ 128.07 | 1.94 % | $ 15.3 B | USA |
 |
Bio-Techne Corporation
TECH
|
11 B | $ 72.69 | 0.2 % | $ 11.3 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
1.26 B | $ 36.84 | 1.97 % | $ 2.12 B | USA |
 |
Immuron Limited
IMRN
|
230 M | $ 0.96 | 0.25 % | $ 222 M |  Australia |
 |
Immunic
IMUX
|
160 M | $ 7.28 | -1.75 % | $ 1.13 B | USA |
 |
Immunovant
IMVT
|
5.69 B | $ 28.19 | -0.79 % | $ 5.14 B | USA |
 |
INmune Bio
INMB
|
12.3 M | $ 1.43 | -2.05 % | $ 35.4 M | USA |
 |
Insmed Incorporated
INSM
|
32.6 B | $ 93.44 | 0.05 % | $ 18.6 B | USA |
 |
Ionis Pharmaceuticals
IONS
|
15.6 B | $ 43.42 | 1.13 % | $ 6.95 B | USA |
 |
Innate Pharma S.A.
IPHA
|
98.2 M | $ 1.47 | -1.64 % | $ 132 M | France |
 |
Ironwood Pharmaceuticals
IRWD
|
-115 M | $ 3.49 | 0.87 % | $ 565 M | USA |
 |
Inventiva S.A.
IVA
|
313 M | $ 3.67 | -1.08 % | $ 219 M | France |
 |
Jazz Pharmaceuticals plc
JAZZ
|
9.15 B | $ 205.67 | -3.89 % | $ 12.5 B |  Irlanda |
 |
Johnson & Johnson
JNJ
|
98 B | $ 266.51 | 1.02 % | $ 642 B | USA |
 |
Kamada Ltd.
KMDA
|
415 M | $ 7.93 | 2.06 % | $ 457 M | Israel |
 |
Krystal Biotech
KRYS
|
8.08 B | $ 313.53 | 0.65 % | $ 9.07 B | USA |
 |
Kura Oncology
KURA
|
1.15 B | $ 9.64 | 0.31 % | $ 845 M | USA |
 |
Kymera Therapeutics
KYMR
|
7.74 B | $ 114.86 | 3.7 % | $ 9.7 B | USA |
 |
Lineage Cell Therapeutics
LCTX
|
450 M | $ 1.0 | -0.1 % | $ 230 M | USA |
 |
Nanobiotix S.A.
NBTX
|
1.45 T | $ 31.65 | 7.8 % | $ 1.51 T | France |
 |
Longeveron
LGVN
|
16.9 B | $ 1.61 | 0.62 % | $ 28.3 B | USA |
 |
Eli Lilly and Company
LLY
|
933 B | $ 1 277.31 | 0.3 % | $ 1.15 T | USA |
 |
Lipocine
LPCN
|
15.2 M | $ 1.43 | -0.69 % | $ 7.79 M | USA |
|
Larimar Therapeutics
LRMR
|
354 M | $ 2.22 | -5.53 % | $ 184 M | USA |
 |
vTv Therapeutics
VTVT
|
-63.5 M | $ 25.97 | 1.64 % | $ 103 M | USA |
 |
Moleculin Biotech
MBRX
|
706 K | $ 6.9 | 6.12 % | $ 8.17 M | USA |
 |
MacroGenics
MGNX
|
293 M | $ 2.17 | -3.56 % | $ 137 M | USA |
 |
Milestone Pharmaceuticals
MIST
|
143 M | $ 0.64 | -0.88 % | $ 68 M | Canada |
 |
Merck & Co.
MRK
|
296 B | $ 140.44 | -3.32 % | $ 351 B | USA |
 |
Moderna
MRNA
|
20.5 B | $ 197.65 | -1.23 % | $ 76.9 B | USA |
 |
Adial Pharmaceuticals
ADIL
|
-3.17 M | $ 3.73 | -4.97 % | $ 2.49 M | USA |
 |
Revolution Medicines
RVMD
|
19.9 B | $ 183.82 | -1.7 % | $ 34.9 B | USA |
 |
Akari Therapeutics, Plc
AKTX
|
8.1 B | $ 7.99 | -2.86 % | $ 538 B | Britain |